Jalen Hurts’ Blood Clot Raises Questions About NFL Team Medical Care
The Jalen Hurts blood clot episode raises a basic question about NFL team medicine: are doctors there to care for players, or to keep them on the field? Comments from Eagles coach Nick Sirianni have brought that tension into focus. The question isn’t whether coaches care about their players. It’s whether a system built around competition can reliably keep a player’s health ahead of the next game.
Asked on Monday who took part in medical discussions about Hurts, Sirianni pointed to the team’s doctors and trainers, saying they were the same staff who helped “21 of our 22 starters be available in the Super Bowl.” He added that they deeply care about the players. His answer was meant to establish trust in the staff, and it may accurately describe their commitment. But it also highlighted the standard by which their work was being praised: getting players ready to compete.
That may be true. But “be available” describes a team objective, not a medical one. A player with a serious health issue is a patient first. When the team employs the doctors making decisions about that player, pressure to get him back into action can compete with the duty to recommend what best protects his health. The conflict can exist even when everyone involved is acting in good faith.
Availability can shape medical decisions
The NFL introduced unaffiliated physicians into concussion decisions after Congress pressed the league to take head trauma seriously. That history points to a wider concern: without independent medical judgment, a doctor who frequently rules players out could be seen as an obstacle and eventually replaced by someone more aligned with the team’s desire to field its strongest lineup. The point of independent review is to create distance between a medical call and the competitive interests surrounding it. A formal safeguard can’t erase every source of pressure, but it can make the decision harder to treat as a coaching choice.
Hurts’ case deserves scrutiny on those terms. The public account has left unanswered questions, while the sequence of events has made it difficult to tell whether the priority was his care or his availability. The concern isn’t proof of improper treatment; it’s that the incentives can pull in different directions. That distinction matters. Asking for clearer explanations is not the same as claiming that the doctors made the wrong call.
The early response to the blood clot appeared focused on what might allow Hurts to play. One reported precaution—that he should not sleep—added to the confusion. Tom Pelissero first reported that Hurts had been told not to sleep and didn’t, then updated his account to say Hurts slept at least briefly at the stadium before the game. The changing details have only sharpened questions about the decisions around his care. Without a fuller account of what clinicians advised and why, the public can’t confidently interpret those reports as a complete medical explanation.
Questions remain about travel
Another unanswered issue is why Hurts was allowed to fly across the Atlantic after doctors diagnosed a blood clot in his leg, less than three days after he had made the same trip with the clot undiagnosed. The public has not been given enough information to assess the medical reasoning. Still, the timing leaves a reasonable question: did the possibility of playing against the Panthers, and in later games, influence the decision? That question calls for an explanation of the reasoning, not a guess about what the doctors knew or weighed.
That question matters even though Hurts avoided a pulmonary embolism, the worst outcome raised by the situation. A good result doesn’t settle whether the risks were assessed with the patient’s health as the first priority. Medical decisions should be judged by the information available when they’re made, not only by what happened afterward. That’s a basic distinction in any discussion of care under uncertainty.
Here’s the thing: players often want to compete, and teams want their best players available. Those shared interests can make a team’s medical staff vulnerable to a different standard of success—one measured by who can play, rather than by the quality of care each player receives. The pressure doesn’t need to arrive as a direct order. It can come from routine expectations, the pace of a season, and the fact that a team’s medical staff works inside an organization whose immediate goal is to win.
What the episode says about trust
This is more significant than it looks. The NFL depends on players trusting medical staff with decisions that can affect their health, and that trust is harder to sustain when the same staff are publicly praised for availability. If you’re working in this space, the practical question is how teams can show that a player’s medical needs set the terms of a return to competition. A clear explanation of who made the decision, what considerations shaped it, and how independent judgment was protected would help answer that question.
And this is the part most people overlook: independence isn’t just about adding another doctor to a process. It also depends on whether that doctor can make an unpopular call without career consequences, and whether players understand that they can raise concerns without being treated as a roster problem. Similar systems typically rely on clear authority and transparent procedures, though the details vary. Without those protections, the label “independent” can offer less reassurance than it suggests.
The league and its teams should examine how those decisions are made, including the role of independent medical judgment. The public record here doesn’t establish that Hurts was mistreated, and it doesn’t resolve the medical reasoning behind the travel or other decisions. It does show why a fuller account matters. The clearest lesson is simple: “Can he play?” should come after “What care does he need?” And if those questions point in different directions, the second one has to lead.